Productivity loss because of chronic pain in the working age population is a widespread concern internationally. Interventions for chronic pain in working age adults might be expected to achieve enhanced productivity in terms of reduced costs of workers' compensation insurance, reduced disability support, and improved rates of return to work for injured workers. This would require the use of measures of productivity in the evaluation of chronic pain management interventions. The aim of this review was to identify and interpret the productivity outcomes of randomised controlled trials reported by studies that conducted economic evaluations (eg, cost-effectiveness and cost-utility) of chronic pain management interventions in the working age population published from database inception to March 2023. Econlit, Embase, and Pubmed electronic databases were searched, yielding 12 studies that met the selection criteria. All 12 studies used absenteeism to measure productivity, translating return to work measures into indirect costs. Only one study included return to work as a primary outcome. Ten studies found no statistically significant improvements in productivity-related costs. Despite evidence for reduced pain-related disability after pain management interventions, this review suggests that the use of measures for assessing productivity gains is lacking. Including such measures would greatly assist administrators and payers when considering the broader societal benefits of such interventions.

中文翻译：

---

工作年龄人群慢性疼痛管理干预措施的生产力结果；系统的审查。

工作年龄人口因慢性疼痛而导致生产力下降是国际上普遍关注的问题。对工作年龄成年人慢性疼痛的干预措施有望提高生产力，包括降低工人赔偿保险成本、减少残疾支持以及提高受伤工人重返工作岗位的比率。这需要在评估慢性疼痛管理干预措施时使用生产力衡量标准。本综述的目的是确定和解释随机对照试验的生产率结果，这些试验是对工作年龄人群中的慢性疼痛管理干预措施进行经济评估（例如，成本效益和成本效用）的研究报告的，从数据库建立到发布2023 年 3 月。检索了 Econlit、Embase 和 Pubmed 电子数据库，得出了 12 项符合选择标准的研究。所有 12 项研究都使用缺勤率来衡量生产力，将重返工作岗位的衡量标准转化为间接成本。只有一项研究将重返工作岗位作为主要结果。十项研究发现，与生产力相关的成本没有统计上显着的改善。尽管有证据表明疼痛管理干预后与疼痛相关的残疾有所减少，但本次综述表明，缺乏评估生产力提高的措施。在考虑此类干预措施的更广泛社会效益时，纳入此类措施将极大地帮助管理人员和付款人。